Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 196,762	$ 257,222
Accounts receivable, net	69,048	48,376
Inventory	50,850	39,756
Prepaid expenses and other current assets	6,321	5,213
Total current assets	322,981	350,567
Restricted cash, non-current	3,038	3,038
Property and equipment, net	26,605	28,748
Operating lease right-of-use assets, net	19,267	20,241
Intangible assets, net	1,000	1,204
Other assets	1,251	919
Total assets	374,142	404,717
Current liabilities:
Accounts payable	15,088	13,499
Accrued compensation	18,834	16,885
Deferred revenue	7,989	5,656
Operating lease, current	1,839	1,683
Loan facility derivative liability	2,000	1,886
Other current liabilities	7,896	6,318
Total current liabilities	53,646	45,927
Long-term debt	51,438	51,339
Operating lease, non-current	27,361	26,182
Other liabilities	479	517
Total liabilities	132,924	123,965
Commitments and contingencies (see Note 11)
Stockholders’ equity:
Preferred stock, $0.00001 par value; Authorized shares: 10,000 at September 30, 2024 and December 31, 2023, Issued and outstanding shares: none at September 30, 2024 and December 31, 2023	0	0
Common stock, $0.00001 par value; Authorized shares: 300,000 at September 30, 2024 and December 31, 2023, Issued and outstanding shares: 51,900 and 50,771 at September 30, 2024 and December 31, 2023, respectively	0	0
Additional paid-in capital	768,365	735,240
Accumulated other comprehensive gain (loss)	(18)	84
Accumulated deficit	(527,129)	(454,572)
Total stockholders’ equity	241,218	280,752
Total liabilities and stockholders’ equity	$ 374,142	$ 404,717